Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
139 hedge funds and large institutions have $474M invested in Surmodics in 2024 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 45 increasing their positions, 39 reducing their positions, and 12 closing their positions.
117% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 12
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
95% more call options, than puts
Call options by funds: $1.33M | Put options by funds: $681K
15% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 39
10% more funds holding
Funds holding: 126 → 139 (+13)
1.05% more ownership
Funds ownership: 82.77% → 83.82% (+1%)
4% more capital invested
Capital invested by funds: $458M → $474M (+$16.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$11.7M |
| 2 |
BHMP
Bardin Hill Management Partners
New York
|
+$7.31M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$4.83M |
| 4 |
Squarepoint
New York
|
+$3.83M |
| 5 |
BGIM
Boussard & Gavaudan Investment Management
London,
United Kingdom
|
+$3.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$29.2M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$9.48M |
| 3 |
TI
Trigran Investments
Northbrook,
Illinois
|
-$6.81M |
| 4 |
CM
Capula Management
Grand Cayman,
Cayman Islands
|
-$5.14M |
| 5 |
Morgan Stanley
New York
|
-$3.04M |
SRDX Hedge Fund Activity: Q4 2024 in Review
139 of the 7,606 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q4 2024, worth a combined $474M — up 3.5% from $458M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new SRDX positions and 12 closed out — a net gain of 14 holders — while 45 added to existing stakes and 39 trimmed.
The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $11.7M. The largest seller was Beryl Capital Management, cutting an estimated $29.2M.
- 139 institutional investors held Surmodics (SRDX) as of Q4 2024, up from 126 in Q3 2024.
- Funds reported $474M of Surmodics stock for Q4 2024, up 3.5% quarter-over-quarter.
- 26 funds opened new Surmodics positions in Q4 2024 and 12 closed out, a net change of +14 holders.
- The largest Surmodics buyer in Q4 2024 was Hudson Bay Capital Management, an estimated $11.7M added.
- The largest Surmodics seller in Q4 2024 was Beryl Capital Management, an estimated $29.2M sold.
Based on aggregated 13F filings for Q4 2024.